David Nierengarten's Stock Ratings

Wedbush Analyst

David Nierengarten is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/29/2024

Overall Average Return

29.7%

Smart Score

77.2%

Overall Average Return Percentile

87th

Number of Ratings

114
Buy NowGet Alert
05/29/2024IKNABuy Now
Ikena Oncology
$1.5826.58%$8 → $2DowngradeOutperform → NeutralGet Alert
05/24/2024COGTBuy Now
Cogent Biosciences
$8.4118.91% → $10ReiteratesNeutral → NeutralGet Alert
05/24/2024NUVBBuy Now
Nuvation Bio
$2.9768.48% → $5ReiteratesOutperform → OutperformGet Alert
05/17/2024NUVLBuy Now
Nuvalent
$67.0847.58% → $99ReiteratesOutperform → OutperformGet Alert
05/15/2024NUVBBuy Now
Nuvation Bio
$2.9768.48% → $5ReiteratesOutperform → OutperformGet Alert
05/14/2024STROBuy Now
Sutro Biopharma
$4.1891.39% → $8ReiteratesOutperform → OutperformGet Alert
05/14/2024IKNABuy Now
Ikena Oncology
$1.58406.33% → $8ReiteratesOutperform → OutperformGet Alert
05/14/2024GBIOBuy Now
Generation Bio
$3.0762.87% → $5ReiteratesOutperform → OutperformGet Alert
05/10/2024VORBuy Now
Vor Biopharma
$1.52623.68% → $11ReiteratesOutperform → OutperformGet Alert
05/10/2024XNCRBuy Now
Xencor
$23.2954.57%$34 → $36MaintainsOutperformGet Alert
05/10/2024FATEBuy Now
Fate Therapeutics
$3.5441.24%$7 → $5MaintainsNeutralGet Alert
05/06/2024FATEBuy Now
Fate Therapeutics
$3.5497.74% → $7ReiteratesNeutral → NeutralGet Alert
04/26/2024BPMCBuy Now
Blueprint Medicines
$102.367.46% → $110ReiteratesOutperform → OutperformGet Alert
04/23/2024VORBuy Now
Vor Biopharma
$1.52623.68% → $11ReiteratesOutperform → OutperformGet Alert
04/23/2024TCRXBuy Now
TScan Therapeutics
$8.7314.55% → $10ReiteratesOutperform → OutperformGet Alert
04/23/2024PRMEBuy Now
Prime Medicine
$6.5084.62% → $12ReiteratesOutperform → OutperformGet Alert
04/23/2024FATEBuy Now
Fate Therapeutics
$3.5497.74% → $7ReiteratesNeutral → NeutralGet Alert
04/23/2024NTLABuy Now
Intellia Therapeutics
$22.2730.22% → $29ReiteratesNeutral → NeutralGet Alert
04/23/2024BEAMBuy Now
Beam Therapeutics
$24.16135.93% → $57ReiteratesOutperform → OutperformGet Alert
04/18/2024ARGXBuy Now
argenx
$388.0034.28% → $521ReiteratesOutperform → OutperformGet Alert
04/03/2024PRMEBuy Now
Prime Medicine
$6.5084.62% → $12Initiates → OutperformGet Alert
04/02/2024PRMEBuy Now
Prime Medicine
$6.5084.62% → $12Initiates → OutperformGet Alert
04/01/2024IMNMBuy Now
Immunome
$14.34130.13%$27 → $33MaintainsOutperformGet Alert
03/26/2024STROBuy Now
Sutro Biopharma
$4.1891.39%$12 → $8MaintainsOutperformGet Alert
03/21/2024VORBuy Now
Vor Biopharma
$1.52623.68% → $11ReiteratesOutperform → OutperformGet Alert
03/19/2024BLUEBuy Now
bluebird bio
$0.9380.65%$3 → $1.68MaintainsNeutralGet Alert
03/18/2024TSVTBuy Now
2seventy bio
$4.2717.1% → $5ReiteratesNeutral → NeutralGet Alert
03/12/2024ORICBuy Now
ORIC Pharmaceuticals
$9.00122.22% → $20ReiteratesOutperform → OutperformGet Alert
03/07/2024GBIOBuy Now
Generation Bio
$3.0762.87% → $5ReiteratesOutperform → OutperformGet Alert
03/01/2024NUVBBuy Now
Nuvation Bio
$2.9768.48% → $5ReiteratesOutperform → OutperformGet Alert